Screening compound: C20H22N4O2S (D475-2422)

Screening compound: C<sub>20</sub>H<sub>22</sub>N<sub>4</sub>O<sub>2</sub>S (D475-2422)
Screening compound: C<sub>20</sub>H<sub>22</sub>N<sub>4</sub>O<sub>2</sub>S (D475-2422) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C20H22N4O2S (D475-2422)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D475-2422

Molecular Formula

C20H22N4O2S (C20 H22 N4 O2 S)

Compound Name

3-[5-hydroxy-3-methyl-1-(4-phenyl-1,3-thiazol-2-yl)-1H-pyrazol-4-yl]-1-(pyrrolidin-1-yl)propan-1-one

IUPAC name

3-[5-hydroxy-3-methyl-1-(4-phenyl-13-thiazol-2-yl)-1H-pyrazol-4-yl]-1-(pyrrolidin-1-yl)propan-1-one

SMILES

Cc(c(CCC(N1CCCC1)=O)c1O)nn1-c1nc(-c2ccccc2)cs1

InChI

InChI=1S/C20H22N4O2S/c1-14-16(9-10-18(25)23-11-5-6-12-23)19(26)24(22-14)20-21-17(13-27-20)15-7-3-2-4-8-15/h2-4,7-8,13,26H,5-6,9-12H2,1H3

InChI Key

BFAACYZBHXQWCN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27588632

C20H22N4O2S (D475-2422) in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

GPCR Targeted Library (31838 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

SmartTM Library (51161 compounds)

Anti-HIV1 Library (19540 compounds)

Epigenetics Focused Set (26518 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • Epigenetic
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with C20H22N4O2S (D475-2422) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C20H22N4O2S (D475-2422)?
Check Price and Availability of C20H22N4O2S (D475-2422), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C20H22N4O2S (D475-2422) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C20H22N4O2S (D475-2422)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C20H22N4O2S (D475-2422)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C20H22N4O2S (D475-2422) available by request